Destiny Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Destiny Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 438% to $831,552. The net income raised on -$5,657,036 and profit margin reached -680%. Total operating expenses were $7,395,315.

Profit Margin

Destiny Pharma plc (LSE:DEST.L): Profit margin
2014 0 -1.76M
2015 0 -1.01M
2016 0 -1.25M
2017 0 -2.97M
2018 0 -5.16M
2019 305.90K -4.70M -1539.04%
2020 12.45K -5.41M -43462.47%
2021 135.02K -5.33M -3954.35%
2022 154.49K -6.50M -4209.46%
2023 831.55K -5.65M -680.3%

DEST.L Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
831.55K154.49K135.02K12.45K305.90K00000
Cost of revenue
6.19K12.32K12.51K16.88K18.44K9.66K2.07K1.33K00
Gross profit
825.35K142.17K122.51K-4.43K287.46K-9.66K-2.07K-1.33K00
Operating exp.
Research and development
1.76M3.27M2.38M3.22M2.85M3.47M387.45K496.35K274.34K1.09M
Selling and marketing
-6.19K-3.32M-2.38M-3.25M-2.91M0-388.20K000
Total operating expenses
7.39M7.87M6.42M6.53M5.82M6.08M2.72M1.44M1.20M2.07M
Operating income
-6.56M-7.88M-6.43M-6.55M-5.84M-6.08M-2.72M-1.44M-1.20M-2.07M
Other income (expenses), net
123.72K174.62K162.30K71.61K323.59K75.99K-488.21K3977.66K10.50K
Income before tax
-6.44M-7.71M-6.27M-6.48M-5.52M-6.00M-3.21M-1.44M-1.19M-2.06M
Income tax expense
-789.20K-1.20M-931.95K-1.06M-813.25K841.14K-233.90K-191.57K-181.93K-303.27K
Net income
-5.65M-6.50M-5.33M-5.41M-4.70M-5.16M-2.97M-1.25M-1.01M-1.76M
Earnings per share
Basic EPS
-0.06-0.09-0.08-0.12-0.11-0.12-0.08-0.03-0.02-0.04
Diluted EPS
-0.06-0.09-0.08-0.12-0.11-0.12-0.08-0.03-0.02-0.04
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source